BioHealth News Archive
Emergent BioSolutions unveils 7th pandemic CDMO contract, this time for Humanigen’s late-stage antibody hopeful | FiercePharma
Manufacturing powerhouse Emergent BioSolutions unveiled its seventh COVID-19 CDMO tie-up Monday, this time to help crank out Humanigen’s late-stage antibody hopeful lenzilumab. Emergent will…
Read MoreHealthworx and LifeBridge Health Launch Startup Incubator: 1501 Health
Newswise — Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShieldis partnering with LifeBridge Health to launch 1501 Health, an incubator for healthcare…
Read MoreOn Demand Pharmaceuticals picks Rockville for new HQ – Washington Business Journal
The move solidifies the company’s local presence about four months after it secured a temporary occupancy permit in September. Image: Ben Wu is CEO…
Read More
It’s not too soon to start thinking about the next pandemic | LinkedIn
One of the questions I get asked the most is when I think the world will get back to normal. I understand why. We…
Read More
Novavax Reports Varying Success vs. COVID-19 Variants
Novavax electrified investors last night by announcing that its COVID-19 vaccine NVX-CoV2373 showed efficacy of 89.3% in the company’s first analysis of data from…
Read More
GetWellNetwork scoops up Docent Health | MobiHealthNews
Patient engagement platform GetWellNetwork announced it has acquired patient-messaging company Docent Health for an undisclosed sum. As part of the deal, GetWellNetwork will be…
Read More
Emergent BioSolutions to make J&J COVID-19 vaccine in Baltimore
The Johnson & Johnson one-shot coronavirus vaccine is expected to be a game-changer in fighting COVID-19 -- and it will be made in Baltimore.…
Read More
Pharma Giant Roche Partners for Quantum Drug Discovery
Earlier this month we posited the idea that 2021 could be the year of quantum computing-led drug discovery and predicted that partnerships like those…
Read More
Six Biotechs to Watch in 2021 – BioBuzz
2020 was an interesting year for the biotech industry and the BioHealth Capital Region as we adjusted to continue moving forward during the COVID-19…
Read More
European Medicines Agency recommends conditional marketing authorisation to ChAdOx1 coronavirus vaccine – Vaccitech
Oxford, UK – Vaccitech Ltd announces that the European Medicines Agency (EMA) has today recommended the conditional marketing authorisation of the ChAdOx1 nCoV-19 coronavirus vaccine…
Read More
Task Force Recommends Regional Hydrogen Center; Discusses Delivery of Strategic Initiatives
WASHINGTON, D.C., January 29, 2021 – Connected DMV’s COVID-19 Strategic Renewal Task Force held its seventh meeting on Thursday, adopting a recommendation to proactively…
Read More
COVID-19 Vaccine Handling Toolkit
Recent challenges around preparing, transporting, and administering COVID-19 vaccines have received national and international attention. As part of our ongoing COVID-19 response, the U.S…
Read More
Veralox Therapeutics Announces FDA Orphan Drug Designation for VLX-1005
FREDERICK, Md – January 26, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases…
Read More
New “Virginia Bio-Connect” Statewide Consortium and Scale-Up Initiative Featured on BioTalk
Amy Adams with George Mason University. Nikki Hastings with CvilleBioHub, and John Newby with Virginia Bio join Rich Bendis to discuss the new “Virginia…
Read More
STEM Talent Challenge Awardees Announced
EDA is pleased to announce today that seven organizations from across the United States have been awarded a total of $2 million in grants…
Read More